114 related articles for article (PubMed ID: 38884092)
21. A randomized phase III study between sequential versus simultaneous integrated boost intensity-modulated radiation therapy in nasopharyngeal carcinoma.
Lertbutsayanukul C; Prayongrat A; Kannarunimit D; Chakkabat C; Netsawang B; Kitpanit S
Strahlenther Onkol; 2018 May; 194(5):375-385. PubMed ID: 29302704
[TBL] [Abstract][Full Text] [Related]
22. A randomized phase II/III study of adverse events between sequential (SEQ) versus simultaneous integrated boost (SIB) intensity modulated radiation therapy (IMRT) in nasopharyngeal carcinoma; preliminary result on acute adverse events.
Songthong AP; Kannarunimit D; Chakkabat C; Lertbutsayanukul C
Radiat Oncol; 2015 Aug; 10():166. PubMed ID: 26253488
[TBL] [Abstract][Full Text] [Related]
23. Positron emission tomography for staging locally advanced cervical cancer and assessing intensity modulated radiotherapy approach.
Draghini L; Costantini S; Vicenzi L; Italiani M; Loreti F; Trippa F; Arcidiacono F; Casale M; Mantello G; Maranzano E
Radiol Med; 2019 Sep; 124(9):819-825. PubMed ID: 30904982
[TBL] [Abstract][Full Text] [Related]
24. Use of simultaneous radiation boost achieves high treatment response rate in patients with metastatic gastric cancer.
Yang J; Liu J; Gao S; Yang Y; Kong W; Ren W; Zhu L; Yang M; Wei J; Zou Z; Qian X; Liu B; Yan J
J Cancer Res Ther; 2018 Jan; 14(1):36-39. PubMed ID: 29516956
[TBL] [Abstract][Full Text] [Related]
25. Randomized controlled study comparing simultaneous modulated accelerated radiotherapy versus simultaneous integrated boost intensity modulated radiotherapy in the treatment of locally advanced head and neck cancer.
Tandon S; Gairola M; Ahlawat P; Rawat S; Aggarwal A; Sharma K; Tiwari S; Karimi AM; Muttagi V; Sachdeva N; Bhushan M
J Egypt Natl Canc Inst; 2018 Sep; 30(3):107-115. PubMed ID: 29960876
[TBL] [Abstract][Full Text] [Related]
26. Definitive Simultaneous Integrated Boost Versus Conventional-Fractionated Intensity Modulated Radiotherapy for Patients With Advanced Esophageal Squamous Cell Carcinoma: A Propensity Score-Matched Analysis.
Li C; Tan L; Liu X; Wang X; Zhou Z; Chen D; Feng Q; Liang J; Lv J; Wang X; Bi N; Deng L; Wang W; Zhang T; Ni W; Chang X; Han W; Xiao Z
Front Oncol; 2021; 11():618776. PubMed ID: 34235073
[TBL] [Abstract][Full Text] [Related]
27. A comparison of clinical outcomes between simultaneous integrated boost (SIB) versus sequential boost (SEQ) intensity modulated radiation therapy (IMRT) for head and neck cancer: A meta-analysis.
Jiang L; Zhang Y; Yang Z; Liang F; Wu J; Wang R
Medicine (Baltimore); 2019 Aug; 98(34):e16942. PubMed ID: 31441887
[TBL] [Abstract][Full Text] [Related]
28. Prospective evaluation of Intensity Modulated Radiation Therapy with Simultaneous Integrated Boost (IMRT-SIB) in head and neck squamous cell carcinoma in patients not suitable for chemo-radiotherapy.
Rastogi M; Sapru S; Gupta P; Gandhi AK; Mishra SP; Srivastava AK; Khurana R; Hadi R; Sahni K; S F
Oral Oncol; 2017 Apr; 67():10-16. PubMed ID: 28351562
[TBL] [Abstract][Full Text] [Related]
29. Simultaneous integrated boost of intensity-modulated radiation therapy to Stage II-III non-small cell lung cancer with metastatic lymph nodes.
Li QS; Liang N; Ouyang WW; Su SF; Ma Z; Geng YC; Yang WG; Hu YX; Li HQ; Lu B
Cancer Med; 2020 Nov; 9(22):8364-8372. PubMed ID: 32902184
[TBL] [Abstract][Full Text] [Related]
30. Clinical outcomes of conventional HDR intracavitary brachytherapy combined with complementary applicator-guided intensity modulated radiotherapy boost in patients with bulky cervical tumour.
Lu S; Wang S; Kim RY; Zhang J; Wang X; Wang W; Zhu G; Zhou J; Tan Y; Tan M; Li M; Yin G; Li J; Feng M; Lang J
BJOG; 2023 Jan; 130(2):231-237. PubMed ID: 36330947
[TBL] [Abstract][Full Text] [Related]
31. Long-term outcome and late toxicities of simultaneous integrated boost-intensity modulated radiotherapy in pediatric and adolescent nasopharyngeal carcinoma.
Tao CJ; Liu X; Tang LL; Mao YP; Chen L; Li WF; Yu XL; Liu LZ; Zhang R; Lin AH; Ma J; Sun Y
Chin J Cancer; 2013 Oct; 32(10):525-32. PubMed ID: 24016394
[TBL] [Abstract][Full Text] [Related]
32. Comparison of 3D confromal radiotherapy and intensity modulated radiotherapy with or without simultaneous integrated boost during concurrent chemoradiation for locally advanced head and neck cancers.
Spiotto MT; Weichselbaum RR
PLoS One; 2014; 9(4):e94456. PubMed ID: 24714187
[TBL] [Abstract][Full Text] [Related]
33. A comparison of dosimetric and clinical parameters between different IMRT boost techniques in preoperative rectal cancer.
Karaca S; Aysenur Arli Karacam K
J BUON; 2021; 26(4):1231-1238. PubMed ID: 34564975
[TBL] [Abstract][Full Text] [Related]
34. Comparative analysis of simultaneous integrated boost and sequential boost radiotherapy in node-positive cervical cancer: dosimetric and radiobiological considerations.
Mishra R; Singh S; Patel G; Mandal A; Mishra H; Pandey A; Bahadur B; Singh PK; Sachan S; Tewari M
Radiat Environ Biophys; 2024 May; 63(2):297-306. PubMed ID: 38722389
[TBL] [Abstract][Full Text] [Related]
35. Treatment of high-grade gliomas using escalating doses of hypofractionated simultaneous integrated boost-intensity-modulated radiation therapy in combination with temozolomide: A modified Phase I clinical trial.
Ge X; Xue X; Liu H; Wang Y; Xiao Z; Tian L; Chang X; Lin Q; Yu J
J Cancer Res Ther; 2018; 14(7):1482-1491. PubMed ID: 30589027
[TBL] [Abstract][Full Text] [Related]
36. Outcome and toxicity of intensity-modulated radiotherapy with simultaneous integrated boost in patients with pharyngo-laryngeal cancer.
Fondevilla Soler A; López-Guerra JL; García Fernández A; Samaniego Conde MA; Belmonte González MJ; Praena-Fernandez JM; Rivin Del Campo E; Alcaraz M; Azinovic I
Clin Transl Oncol; 2019 Jul; 21(7):881-890. PubMed ID: 30506131
[TBL] [Abstract][Full Text] [Related]
37. Efficacy and Toxicity of IMRT-Based Simultaneous Integrated Boost for the Definitive Management of Positive Lymph Nodes in Patients with Cervical Cancer.
Dang YZ; Li P; Li JP; Zhang Y; Zhao LN; Li WW; Wei LC; Shi M
J Cancer; 2019; 10(5):1103-1109. PubMed ID: 30854117
[No Abstract] [Full Text] [Related]
38. Intensity-modulated radiotherapy with simultaneous integrated boost for locoregionally advanced nasopharyngeal carcinoma.
Yi J; Huang X; Gao L; Luo J; Zhang S; Wang K; Qu Y; Xiao J; Xu G
Radiat Oncol; 2014 Feb; 9():56. PubMed ID: 24533569
[TBL] [Abstract][Full Text] [Related]
39. Clinical analysis of prophylactic para-aortic intensity-modulated radiation in cervical cancer.
Jin G; Li K; Niu S; Liu S; Zhang Q; Fan X
Clin Radiol; 2023 Feb; 78(2):e77-e84. PubMed ID: 36195500
[TBL] [Abstract][Full Text] [Related]
40. Chemoradiotherapy by intensity-modulated radiation therapy with simultaneous integrated boost in locally advanced or oligometastatic non-small-cell lung cancer-a two center experience.
Mantel F; Müller E; Kleine P; Zimmermann M; Exner F; Richter A; Weick S; Ströhle S; Polat B; Höcht S; Flentje M
Strahlenther Onkol; 2021 May; 197(5):405-415. PubMed ID: 33725133
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
